Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes unti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2022-04, Vol.45 (4), p.811-818
Hauptverfasser: Ruuskanen, Matti O, Erawijantari, Pande P, Havulinna, Aki S, Liu, Yang, Méric, Guillaume, Tuomilehto, Jaakko, Inouye, Michael, Jousilahti, Pekka, Salomaa, Veikko, Jain, Mohit, Knight, Rob, Lahti, Leo, Niiranen, Teemu J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 818
container_issue 4
container_start_page 811
container_title Diabetes care
container_volume 45
creator Ruuskanen, Matti O
Erawijantari, Pande P
Havulinna, Aki S
Liu, Yang
Méric, Guillaume
Tuomilehto, Jaakko
Inouye, Michael
Jousilahti, Pekka
Salomaa, Veikko
Jain, Mohit
Knight, Rob
Lahti, Leo
Niiranen, Teemu J
description To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation. Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04-1.42), C. bolteae (HR 1.20; 95% CI 1.04-1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01-1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01-1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02-1.38) and cluster 5 (HR 1.18; 95% CI 1.02-1.36), mostly consisted of these same species. We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.
doi_str_mv 10.2337/dc21-2358
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9016732</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2651848259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-3de25be6ec149ebc072635e78b6118b82bf0b839b2e1a1aad60e8877daa45cf03</originalsourceid><addsrcrecordid>eNpdkUtv1TAQhS0EopfCgj-ALLEBqQE_E2eDVF1ouVIRXZS1ZTsTrqvEDrZTqf8eX_oQsJrFfOfozByEXlPygXHefRwcow3jUj1BG9pz2Ugp1FO0IVT0jex7doRe5HxNCBFCqefoiEtKCBfdBuXzteBv3qVofZwBb-O8xOyLjwHvMr5MMHhX_A3gOOJdcH6AUPDV7QKY4c_eWCiQsQ_Y4Mu4rJP5o9zGfUzlIJEnsmP4zIfg8x6fDutU8kv0bDRThlf38xj9OPtytf3aXHw_321PLxonCC8NH4BJCy24egZYRzrWcgmdsi2lyipmR2IV7y0DaqgxQ0tAqa4bjBHSjYQfo093vstqZxhcTZ7MpJfkZ5NudTRe_7sJfq9_xhvdE9p2nFWDd_cGKf5aIRc9--xgmkyAuGbNWibaljIiKvr2P_Q6rinU8yolqRKKyb5S7--o-u-cE4yPYSjRhyr1oUp9qLKyb_5O_0g-dMd_A1cEmSY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2651848259</pqid></control><display><type>article</type><title>Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ruuskanen, Matti O ; Erawijantari, Pande P ; Havulinna, Aki S ; Liu, Yang ; Méric, Guillaume ; Tuomilehto, Jaakko ; Inouye, Michael ; Jousilahti, Pekka ; Salomaa, Veikko ; Jain, Mohit ; Knight, Rob ; Lahti, Leo ; Niiranen, Teemu J</creator><creatorcontrib>Ruuskanen, Matti O ; Erawijantari, Pande P ; Havulinna, Aki S ; Liu, Yang ; Méric, Guillaume ; Tuomilehto, Jaakko ; Inouye, Michael ; Jousilahti, Pekka ; Salomaa, Veikko ; Jain, Mohit ; Knight, Rob ; Lahti, Leo ; Niiranen, Teemu J</creatorcontrib><description>To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation. Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04-1.42), C. bolteae (HR 1.20; 95% CI 1.04-1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01-1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01-1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02-1.38) and cluster 5 (HR 1.18; 95% CI 1.02-1.36), mostly consisted of these same species. We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc21-2358</identifier><identifier>PMID: 35100347</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adult ; Adults ; Clusters ; Cohort Studies ; Composition ; Cross-Sectional Studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - epidemiology ; Diet ; Digestive system ; Epidemiology ; Epidemiology/Health Services Research ; Feces ; Female ; Finland - epidemiology ; Gastrointestinal Microbiome - genetics ; Health risks ; Humans ; Intestinal microflora ; Male ; Metabolic disorders ; Microbiomes ; Microbiota ; Middle Aged ; Regression analysis ; Regression models ; Research design ; Species ; Therapeutic targets</subject><ispartof>Diabetes care, 2022-04, Vol.45 (4), p.811-818</ispartof><rights>2022 by the American Diabetes Association.</rights><rights>Copyright American Diabetes Association Apr 2022</rights><rights>2022 by the American Diabetes Association 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-3de25be6ec149ebc072635e78b6118b82bf0b839b2e1a1aad60e8877daa45cf03</citedby><cites>FETCH-LOGICAL-c403t-3de25be6ec149ebc072635e78b6118b82bf0b839b2e1a1aad60e8877daa45cf03</cites><orcidid>0000-0003-4221-2880</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35100347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruuskanen, Matti O</creatorcontrib><creatorcontrib>Erawijantari, Pande P</creatorcontrib><creatorcontrib>Havulinna, Aki S</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Méric, Guillaume</creatorcontrib><creatorcontrib>Tuomilehto, Jaakko</creatorcontrib><creatorcontrib>Inouye, Michael</creatorcontrib><creatorcontrib>Jousilahti, Pekka</creatorcontrib><creatorcontrib>Salomaa, Veikko</creatorcontrib><creatorcontrib>Jain, Mohit</creatorcontrib><creatorcontrib>Knight, Rob</creatorcontrib><creatorcontrib>Lahti, Leo</creatorcontrib><creatorcontrib>Niiranen, Teemu J</creatorcontrib><title>Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation. Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04-1.42), C. bolteae (HR 1.20; 95% CI 1.04-1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01-1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01-1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02-1.38) and cluster 5 (HR 1.18; 95% CI 1.02-1.36), mostly consisted of these same species. We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.</description><subject>Adult</subject><subject>Adults</subject><subject>Clusters</subject><subject>Cohort Studies</subject><subject>Composition</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diet</subject><subject>Digestive system</subject><subject>Epidemiology</subject><subject>Epidemiology/Health Services Research</subject><subject>Feces</subject><subject>Female</subject><subject>Finland - epidemiology</subject><subject>Gastrointestinal Microbiome - genetics</subject><subject>Health risks</subject><subject>Humans</subject><subject>Intestinal microflora</subject><subject>Male</subject><subject>Metabolic disorders</subject><subject>Microbiomes</subject><subject>Microbiota</subject><subject>Middle Aged</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Research design</subject><subject>Species</subject><subject>Therapeutic targets</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtv1TAQhS0EopfCgj-ALLEBqQE_E2eDVF1ouVIRXZS1ZTsTrqvEDrZTqf8eX_oQsJrFfOfozByEXlPygXHefRwcow3jUj1BG9pz2Ugp1FO0IVT0jex7doRe5HxNCBFCqefoiEtKCBfdBuXzteBv3qVofZwBb-O8xOyLjwHvMr5MMHhX_A3gOOJdcH6AUPDV7QKY4c_eWCiQsQ_Y4Mu4rJP5o9zGfUzlIJEnsmP4zIfg8x6fDutU8kv0bDRThlf38xj9OPtytf3aXHw_321PLxonCC8NH4BJCy24egZYRzrWcgmdsi2lyipmR2IV7y0DaqgxQ0tAqa4bjBHSjYQfo093vstqZxhcTZ7MpJfkZ5NudTRe_7sJfq9_xhvdE9p2nFWDd_cGKf5aIRc9--xgmkyAuGbNWibaljIiKvr2P_Q6rinU8yolqRKKyb5S7--o-u-cE4yPYSjRhyr1oUp9qLKyb_5O_0g-dMd_A1cEmSY</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Ruuskanen, Matti O</creator><creator>Erawijantari, Pande P</creator><creator>Havulinna, Aki S</creator><creator>Liu, Yang</creator><creator>Méric, Guillaume</creator><creator>Tuomilehto, Jaakko</creator><creator>Inouye, Michael</creator><creator>Jousilahti, Pekka</creator><creator>Salomaa, Veikko</creator><creator>Jain, Mohit</creator><creator>Knight, Rob</creator><creator>Lahti, Leo</creator><creator>Niiranen, Teemu J</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4221-2880</orcidid></search><sort><creationdate>20220401</creationdate><title>Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults</title><author>Ruuskanen, Matti O ; Erawijantari, Pande P ; Havulinna, Aki S ; Liu, Yang ; Méric, Guillaume ; Tuomilehto, Jaakko ; Inouye, Michael ; Jousilahti, Pekka ; Salomaa, Veikko ; Jain, Mohit ; Knight, Rob ; Lahti, Leo ; Niiranen, Teemu J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-3de25be6ec149ebc072635e78b6118b82bf0b839b2e1a1aad60e8877daa45cf03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Clusters</topic><topic>Cohort Studies</topic><topic>Composition</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diet</topic><topic>Digestive system</topic><topic>Epidemiology</topic><topic>Epidemiology/Health Services Research</topic><topic>Feces</topic><topic>Female</topic><topic>Finland - epidemiology</topic><topic>Gastrointestinal Microbiome - genetics</topic><topic>Health risks</topic><topic>Humans</topic><topic>Intestinal microflora</topic><topic>Male</topic><topic>Metabolic disorders</topic><topic>Microbiomes</topic><topic>Microbiota</topic><topic>Middle Aged</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Research design</topic><topic>Species</topic><topic>Therapeutic targets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruuskanen, Matti O</creatorcontrib><creatorcontrib>Erawijantari, Pande P</creatorcontrib><creatorcontrib>Havulinna, Aki S</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Méric, Guillaume</creatorcontrib><creatorcontrib>Tuomilehto, Jaakko</creatorcontrib><creatorcontrib>Inouye, Michael</creatorcontrib><creatorcontrib>Jousilahti, Pekka</creatorcontrib><creatorcontrib>Salomaa, Veikko</creatorcontrib><creatorcontrib>Jain, Mohit</creatorcontrib><creatorcontrib>Knight, Rob</creatorcontrib><creatorcontrib>Lahti, Leo</creatorcontrib><creatorcontrib>Niiranen, Teemu J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruuskanen, Matti O</au><au>Erawijantari, Pande P</au><au>Havulinna, Aki S</au><au>Liu, Yang</au><au>Méric, Guillaume</au><au>Tuomilehto, Jaakko</au><au>Inouye, Michael</au><au>Jousilahti, Pekka</au><au>Salomaa, Veikko</au><au>Jain, Mohit</au><au>Knight, Rob</au><au>Lahti, Leo</au><au>Niiranen, Teemu J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>45</volume><issue>4</issue><spage>811</spage><epage>818</epage><pages>811-818</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract>To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation. Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04-1.42), C. bolteae (HR 1.20; 95% CI 1.04-1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01-1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01-1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02-1.38) and cluster 5 (HR 1.18; 95% CI 1.02-1.36), mostly consisted of these same species. We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>35100347</pmid><doi>10.2337/dc21-2358</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4221-2880</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2022-04, Vol.45 (4), p.811-818
issn 0149-5992
1935-5548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9016732
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adult
Adults
Clusters
Cohort Studies
Composition
Cross-Sectional Studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - epidemiology
Diet
Digestive system
Epidemiology
Epidemiology/Health Services Research
Feces
Female
Finland - epidemiology
Gastrointestinal Microbiome - genetics
Health risks
Humans
Intestinal microflora
Male
Metabolic disorders
Microbiomes
Microbiota
Middle Aged
Regression analysis
Regression models
Research design
Species
Therapeutic targets
title Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A26%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gut%20Microbiome%20Composition%20Is%20Predictive%20of%20Incident%20Type%202%20Diabetes%20in%20a%20Population%20Cohort%20of%205,572%20Finnish%20Adults&rft.jtitle=Diabetes%20care&rft.au=Ruuskanen,%20Matti%20O&rft.date=2022-04-01&rft.volume=45&rft.issue=4&rft.spage=811&rft.epage=818&rft.pages=811-818&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dc21-2358&rft_dat=%3Cproquest_pubme%3E2651848259%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2651848259&rft_id=info:pmid/35100347&rfr_iscdi=true